High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas

Carole Colin (1) , Brigitte Voutsinos-Porche (1) , Isabelle Nanni (2) , Frederic Fina (2) , Philippe Metellus (3) , Dominique Intagliata (1) , Nathalie Baeza (1) , Corinne Bouvier (4, 1) , Christine Delfino (1) , Anderson Loundou (5) , Olivier Chinot (6, 1, 2) , Tamara Lah , Janko Kos (7) , Pierre-Marie Martin (2) , L’houcine Ouafik (1, 2) , Dominique Figarella-Branger (4, 1)

1 CRO2 - Centre de Recherches en Oncologie biologique et Oncopharmacologie
2 Laboratoire de Transfert d'Oncologie Biologique [Hôpital Nord - APHM]
3 Département de Neurochirurgie [CHU Timone]
4 Service d’Anatomopathologie
5 Unité d'Aide Méthodologique
6 Département de neurooncologie
7 Faculty of Pharmacy

Domains: Life Sciences [q-bio]; Cancer

Carole Colin, Brigitte Voutsinos-Porche, Isabelle Nanni, Frederic Fina, Philippe Metellus, et al.. High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas. Acta Neuropathologica, 2009, 118 (6), pp.745 - 754. ⟨10.1007/s00401-009-0592-2⟩. ⟨hal-01848025⟩